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Abstract
 
Inflammation induced by circulating immunoglobulin G–immune complexes (ICs) character-
izes many immune-mediated diseases. In this work, the molecular requirements for the deposi-
tion of circulating ICs and subsequent acute leukocyte recruitment in mice were elucidated.
We show that after intravenous injection, preformed soluble ICs are rapidly deposited in the
postcapillary venules of the cremaster microcirculation, secondary to increased vascular perme-
ability. This deposition is dependent on complement C1q. IC deposition is associated with leu-
kocyte recruitment. Leukocyte rolling, which is mediated by P-selectin in the exteriorized
cremaster muscle, is not further increased in response to ICs. In contrast, leukocyte rolling
velocity is significantly decreased and leukocyte adhesion is significantly increased in the presence
of ICs. The IC-mediated slow leukocyte rolling velocity and subsequent adhesion and emigra-
tion are dependent on Fc
 
  
 
receptors (Fc
 
 
 
Rs), particularly Fc
 
 
 
RIII, with complement C3 and
C5 having no detectable role. These studies suggest a regulatory mechanism of IC deposition
and leukocyte trafficking in IC-mediated inflammation requiring C1q and Fc
 
 
 
Rs in sequential,
noninteracting roles.
Key words: antigen–antibody complex • Fc receptors • animal models • 
complement 1q • microscopy
 
Introduction
 
Circulating immune complexes (ICs) are produced contin-
uously in response to infection, tissue injury, and immune
reactions to foreign antigens (Ags). Most ICs are of little
pathologic significance because they are rapidly cleared by
hepatic and splenic phagocytes (1, 2). This cycle of IC for-
mation and clearance is an important component of ac-
quired immunity, ensuring removal or processing of Ags.
However, excessive IC accumulation occurs in several
immune-mediated diseases in human patients (3, 4). In par-
ticular, IgG-containing ICs are responsible for the patho-
genesis of systemic lupus erythematosus, rheumatoid arthritis,
vasculitis, and glomerulonephritis (2–4). The factors influ-
encing IC deposition have mostly been determined for the
glomerulus, which has a unique fenestrated vascular bed
that passively traps circulating ICs (2). Mechanisms leading
to deposition of circulating ICs in other vascular beds have
not been fully elucidated. Studies in the skin of human patients
with circulating ICs (5, 6) suggest that altered vascular per-
meability might be an important contributing factor. Evidence
that activated complement components may also be required
for IC deposition has also been provided. C1q, which initiates
the classical complement pathway by attaching to ICs, is
required for IC binding to endothelial cells (ECs) in vitro
(7, 8). Bound C1q ultimately activates C3 to C3b, which
could facilitate IC deposition by binding to cell surfaces (1,
9). Also, C5, which is activated by C3b-based convertases,
appears to be important for IgG–IC deposition in a murine
model of rheumatoid arthritis (10).
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IC deposition initiates a complex cascade of events,
involving adhesion molecules, Fc
 
 
 
Rs, and complement,
which culminate in the recruitment and activation of PMN
and macrophages. In non-IC models of inflammation, se-
lectins support leukocyte rolling, a prerequisite for adhe-
sion mediated by leukocyte-specific integrins (CD18)
interacting with Ig superfamily members on ECs (11). In
the context of IC-mediated diseases, P-selectin was re-
quired for leukocyte rolling in an OVA-induced, IgE-
mediated hypersensitivity reaction and an IgG-mediated re-
verse Arthus reaction in murine cremaster muscles (12–14).
Importantly, ICs bind to Fc
 
 
 
Rs and activate complement,
and both are critical for leukocyte accumulation and subse-
quent clinical disease in many murine models of IC-medi-
ated disease (10, 15). However, the relative importance of
the Fc
 
 
 
R and complement pathway in the pathogenesis of
these diseases is contentious (16, 17) and due to their com-
plexity, the exact mechanisms of leukocyte recruitment
have not been fully elucidated. Several possibilities exist.
IC-mediated activation of Fc
 
 
 
Rs on mast cells or macro-
phages may release inflammatory mediators (e.g., hista-
mine) that up-regulate adhesion molecules (18). Leukocyte
recruitment may also occur through direct interaction of
PMN Fc
 
 
 
Rs with ICs. Specifically, Fc
 
 
 
RIII (a low affinity
Fc
 
 
 
R) promoted the capture of PMN on IC-coated sur-
faces under physiological flow in vitro (19). Complement
activation may recruit leukocytes through chemokine re-
lease and/or up-regulation of EC adhesion molecules (20).
Here we report on a model of circulating IgG-ICs ame-
nable to intravital microscopy (IVM), designed to mimic
human immune-mediated diseases characterized by high
levels of circulating ICs that access tissues through the vas-
culature. Mice injected i.v. with soluble preformed ICs de-
veloped IC deposits in postcapillary venules, not arterioles
and capillaries, within minutes of manipulations, which in-
creased vascular permeability. IC deposition was primarily
dependent on C1q. IC deposition recruited PMN by de-
creasing their P-selectin–dependent rolling velocity and
promoting adherence and subsequent emigration into ex-
travascular tissue. The IC-induced alterations in rolling ve-
locity were dependent on Fc
 
 
 
Rs, whereas adhesion and
emigration were specifically dependent on PMN Fc
 
 
 
RIII.
Our results define a novel in vivo role for C1q in initiating
deposition of circulating ICs and for leukocyte Fc
 
 
 
Rs in
mediating subsequent recruitment, thus suggesting that
complement and Fc
 
 
 
Rs have sequential, but noninteract-
ing, roles in acute IC-mediated inflammation.
 
Materials and Methods
 
Mice.
 
7–16-wk-old male mice were used. P-selection-KO
(
 
 
 
/
 
 
 
) and WT mice (21) were backcrossed nine generations to
C57BL/6J. C1q (C1q
 
   
 
; reference 22), C3 (C3
 
 
 
/
 
 
 
; provided by
M. Carroll, Harvard Medical School, Boston, MA; reference 23),
and platelet-activating receptor
 
 
 
/
 
  
 
mice (provided by S. Ishii and
T. Shimizu, University of Tokyo Bunkyo-ku, Tokyo, Japan; refer-
ence 24), backcrossed 10 generations to C57Bl/6, were also used
with age- and strain-matched controls.
Mice lacking the Fc
 
  
 
chain and Fc
 
 
 
RII, i.e., lacking all three
Fc
 
 
 
Rs, on a mixed background (Fc
 
 
 
R
 
 
 
/
 
 
 
) and controls (B6/
129S6F1) were from Taconic. Fc
 
 
 
RIII (Fc
 
 
 
RIII
 
 
 
/
 
 
 
), C5 (C5
 
 
 
/
 
 
 
),
and two strains of mast cell (Sl/Sl
 
d 
 
and W/W
 
v
 
) KO mice with
controls were from The Jackson Laboratory. Mice were housed
in a virus antibody (Ab)-free facility at Longwood Medical Re-
search Center, Brigham and Women’s Hospital. Experiments
were conducted under a protocol approved by the institutional
animal care and use committee.
 
Preparation and Administration of ICs.
 
Soluble ICs at four to
six times Ag excess were formed using BSA (sterile low endo-
toxin solution; ICN Biomedicals) and polyclonal rabbit anti-BSA
Ab (Sigma-Aldrich), and were injected i.v. The amount of rabbit
IgG injected was 90–165 
 
 
 
g, as determined by ELISA. Injections
of BSA alone or PBS served as controls. ICs were also produced
from DNP-conjugated chicken Ig (Biosearch Technologies) and
goat anti-DNP Ab (Biogenesis). Deposition was evaluated as de-
scribed below. All remaining Abs were from Jackson Immu-
noResearch Laboratories unless otherwise stated.
 
Visualization of IC Deposits.
 
To detect IC deposits, ICs were
labeled in vitro or in vivo with secondary fluorescent Abs as de-
scribed below. The cremaster muscle vasculature was visualized
in real-time using IVM, and then the muscle was harvested as a
whole mount and examined with a fluorescent microscope. ICs
were labeled in vitro with fluorescent-labeled anti–rabbit IgG
(1:10) for 20 min, and then were injected i.v. Whole IgG and
F(ab
 
 
 
)
 
2 
 
fragments of FITC-donkey anti–rabbit IgG, Cy3
 
 
 
 or
FITC-donkey, FITC-mouse (Sigma-Aldrich), and FITC-goat
(Vector Laboratories) anti–rabbit IgGs were used with equivalent
results. The polyclonal rabbit anti-BSA Ab was also directly
FITC conjugated (FluoReporter Fluorescein-EX Kit; Pierce
Chemical Co.) and ICs thus created were deposited similarly to
ICs labeled with secondary Abs. To show that deposition was
specific for ICs, we used the following controls: BSA and specific
secondary Ab (FITC-donkey anti–rabbit IgG), ICs and nonspe-
cific secondary Ab (FITC-donkey anti–goat IgG), FITC-BSA
(Molecular Probes) in PBS, and specific secondary Ab alone in
PBS. To detect deposited unlabeled ICs in vivo, unlabeled ICs or
BSA was injected i.v., followed by 2 
 
  
 
10
 
8 
 
fluorescent (yellow-
green) 1-
 
 
 
m polystyrene microspheres (Polysciences, Inc.) cou-
pled to goat anti–rabbit IgG, given in two boluses at 10-min in-
tervals via the femoral artery. 80 
 
 
 
g Cy3-donkey anti–rabbit IgG
was then given i.v. via the retroorbital plexus. Microsphere accu-
mulation was quantified in whole mounts and expressed as num-
bers per area of harvested muscle.
For detection of ICs by immunohistochemistry (IHC), frozen
OCT-embedded, 6-
 
 
 
m cryostat tissue sections were stained for
rabbit IgG using standard methods and a streptavidin-peroxidase
system (ABC Elite; Vector Laboratories) with amino-ethyl carba-
zide substrate. IHC for C1q, C3, and platelets was performed us-
ing rat anti–murine C1q, C3d (1:20; Cell Science), or CD41
(GPII
 
b
 
, 1:50; BD Biosciences).
 
IVM.
 
Leukocyte recruitment in cremaster muscle venules
was evaluated in mice within 1 h of a single i.v. injection of unla-
beled ICs or controls. Mice were anesthetized with 90 mg/kg
ketamine, 18 mg/kg xylazine, and 0.24 mg/kg atropine. The
cremaster was prepared as described previously (25), which took
15–20 min. The mouse was transferred to saline immersion intra-
vital microscope (Mikron Instruments). Fluorescent signals were
generated by a xenon lamp, video synchronized with a strobo-
scope (model 315-T; Colorado Video), and detected using a sili-
con-intensified camera (Hamamatsu Phototonics). Signals were
transferred through an online image processor (Argus 20; Hama- 
Stokol et al.
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matsu Phototonics) to a video recorder and color monitor (Sony).
Transilluminated light was captured by a CCD camera (Sony)
that was linked to the video recorder. Data from mice were cap-
tured on S-VHS tapes (Maxell) and played back through the Ar-
gus 20 for data analysis.
Endogenous leukocytes were labeled i.v. with 2 mg/ml rho-
damine 6G-chloride (Molecular Probes) and detected with the
silicon-intensified camera. Five to eight venules were analyzed
over 20 min. During analysis, the muscle was bathed in warmed
lactated ringer’s solution, with 185 
 
 
 
M NaHCO
 
3
 
. Centerline
blood flow velocity was measured using a Doppler flow ve-
locimeter (Texas A&M University Health Science Center). The
mouse was then injected i.v. with FITC-dextran (10 mg/ml, 160
kD; Sigma-Aldrich) and venule size was measured with the Argus
20. At the completion of microscopy, blood was collected into
EDTA for total and differential leukocyte counts.
 
Analysis of IVM Data.
 
Leukocyte rolling flux was defined as
the number of leukocytes rolling past a perpendicular point in a
vessel over 60 s. This was converted to the leukocyte rolling flux
fraction as described previously (26). The mean blood flow veloc-
ity (Vb) was calculated as centerline velocity/1.6 and wall shear
rate as 8 (Vb/venule diameter) (13). Leukocyte rolling velocities
were measured by tracking single leukocytes (20/venule) frame by
frame and calculating distance moved per unit time (micrometer/
second). Adherent leukocytes were defined as cells remaining sta-
tionary for 30 s and were expressed per mm
 
2 
 
of venule.
For all mice, analysis was performed in venules ranging from
13 to 66 
 
 
 
m, with Vb of 0.6 to 7.3 mm/s and shear rates of 155
to 2,014 s
 
 
 
1
 
. There were no significant differences (not depicted)
in these parameters or leukocyte counts comparing KO and WT
mice or treatment groups (mice given ICs, BSA, or PBS), unless
otherwise noted.
 
Analysis of Vascular Permeability.
 
Permeability changes were
evaluated using colloidal carbon, which is retained by leaky vessels
and can be assessed microscopically (27, 28), or FITC-dextran.
Mice were given labeled ICs, followed 15 min later by colloidal
carbon i.v. (200 
 
 
 
l of a 1:4 dilution; Sanford-Higgins). Mice were
then killed before or after cremaster exteriorization. To increase EC
barrier function, mice were given 5 mg/kg rolipram and 1 mg/kg
forskolin (R/F; both from Sigma-Aldrich) i.p. 20 min before IC or
30 min before colloidal carbon injection. Deposition was scored by
independent observers. To assess effects of vasoactive mediators,
mice were injected i.v. with labeled ICs, followed within 15 min by
PBS, 37 
 
 
 
g histamine (Sigma-Aldrich), or 100 ng of vascular endo-
thelial growth factor (VEGF; PeproTech) i.p. Mice were then given
colloidal carbon before being killed. H1 receptor antagonists, 30
mg/kg diphenhydramine (Sigma-Aldrich), and 20 mg/kg pyril-
amine (Sigma-Aldrich) were given i.p. 15 min before IC injection.
All harvested muscles from killed mice were pressed onto poly-l-
lysine–coated microscope slides, mounted with Fluorosave (Calbio-
chem), and colloidal carbon and IC deposits were visualized using
phase contrast and fluorescent microscopy, respectively. To evaluate
permeability “real-time” during IVM, leakage of FITC-dextran
into extravascular tissue (a gross indicator of permeability; reference
29) was assessed at the end of the leukocyte recruitment experi-
ments and was subjectively graded (1 to 4
 
 
 
).
 
Detection of Leukocytes in Tissues.
 
Emigrated leukocytes
(numbers/mm
 
2
 
) were counted under transillumination in a 0.25-
mm
 
2 
 
field of extravascular tissue around each analyzed venule, at
the end of the experiment. Extravascular leukocytes were also
counted in Giemsa-stained cremaster whole mounts (26). Plastic-
embedded sections of cremaster were stained for PMN with
chloroacetate-esterase. In addition, differential counts (100 cells)
were performed on extravascular and intravascular leukocytes in
Giemsa-stained whole mounts and expressed as percentages.
 
Detection of Adhesion Molecules in Cremaster Muscle Vessels and
Circulating PMN.
 
IHC for E-selectin, vascular cell adhesion
molecule (VCAM)-1, and intercellular adhesion molecule (ICAM)-1
was performed on frozen sections, as described above using rat
anti–murine E-selectin (BD Biosciences) or VCAM-1 (Cymbus
Biotechnology) and Armenian hamster anti–murine ICAM-1
(BD Biosciences).
Blood was obtained from mice 1 h after IC or BSA injection.
Standard FACS analysis was performed using the following anti–
murine Abs (BD Biosciences) with the following suitable isotype
controls: PE anti–Ly6-G (Gr-1) for PMN, FITC anti–Mac-1,
and FITC anti–L-selectin. Gr-1
 
  
 
cells were gated and FITC
 
 
 
cells were identified on histogram plots.
 
Peripheral Blood Counts and Platelet Purification and Labeling.
 
Blood was collected from the retroorbital plexus into EDTA.
Platelet counts were performed with a Unopette and hemocytom-
eter (Fisher Scientific). Total leukocyte counts were determined
with a Coulter counter (Coulter Electronics). Differential counts
(100 cells) were performed on Wright’s stained blood smears.
For platelet purification, blood was obtained from WT mice into
25 
 
 
 
M heparin (Sigma-Aldrich), centrifuged at 200 
 
g
 
, washed with
modified Tyrode’s buffer (with 1 
 
 
 
M prostaglandin E1; Sigma-
Aldrich), and then labeled with 0.25 
 
 
 
g/ml calcein acetoxymethyl
(Molecular Probes). Labeled platelets were injected i.v. at 10
 
8 
 
cells/
mouse 15 min before ICs. IVM was performed 1 h later.
 
ELISA for Measurement of Rabbit IgG and C3.
 
Concentra-
tions of rabbit IgG in ICs and C3 in sera were determined using a
capture ELISA (30). Capture and detection Abs were unconju-
gated or horseradish peroxidase conjugated with donkey anti–
rabbit IgG or goat anti–murine C3 (Cappel; ICN Biomedicals),
respectively. Serial sample dilutions were compared with stan-
dards (rabbit IgG [Pierce Chemical Co.] or C3 standard [Calbio-
chem]), using regression analysis of OD (450 nm) versus concen-
tration. In the C3 assay, sera from C3
 
 
 
/
 
  
 
mice had ODs below
background, confirming assay specificity.
 
Statistical Analysis.
 
Parametric data were represented as mean 
 
 
 
SEM, whereas nonparametric data were represented by medi-
ans. With parametric data, multiple groups were compared by
analysis of variance. Comparisons between two groups and analysis
of variance differences were further evaluated with a nonpaired
Student’s 
 
t 
 
test with a Bonferroni adjustment. For nonparametric
data, multiple groups were compared with a Kruskal-Wallis test,
followed by a Mann-Whitney U-test (31). A paired 
 
t 
 
test was
used to compare total leukocyte and differential counts, platelet
counts, and C3 levels in mice before and after IC or BSA injec-
tion. Significance was set at P 
 
  
 
0.05.
 
Online Supplemental Material.
 
Video 1 illustrates the granular
deposition of fluorescently labeled ICs occurring in venules of
exteriorized cremasters of anesthetized WT mice. Granule depos-
its do not extend into capillaries and arterioles, which are dif-
fusely stained. Video 2 illustrates slow leukocyte rolling velocity
and several adherent leukocytes after IC injection in WT mice.
Leukocytes roll fast and none are adherent in Fc
 
 
 
R-KO mice.
Videos 1 and 2 are available at http://www.jem.org/cgi/content/
full/jem.20040501/DC1.
 
Results
 
Characterization of Our In Vivo Model of Circulating ICs.
 
To examine whether i.v. injection of preformed ICs in-
duced systemic inflammation, we measured C3 levels, leu- 
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kocyte and platelet counts, and adhesion molecule expres-
sion on ECs and PMN 1 h after injection of ICs or BSA
into WT mice. Serum C3 and total and differential leuko-
cyte counts did not change after IC injection. Platelet
counts decreased by 32% after IC compared with BSA
injection (Table I), which might be due to IC-induced
platelet aggregation (1, 32). Adhesion molecule expression
(E-selectin, ICAM-1, and VCAM-1) was not altered in
cremaster vessels and circulating PMN were not detect-
ably activated (no Mac-1 up-regulation or L-selectin
shedding) after ICs (not depicted). These results indicate
that heterologous ICs do not induce a systemic inflamma-
tory response.
 
Alterations in Vascular Permeability Are Associated with IC
Deposition in Tissues.
 
Previous studies have shown that
ICs only deposit in venules after vascular permeability is in-
duced (33, 34). Indeed, mice killed 1 h after prelabeled ICs
were given i.v. showed no alterations in permeability (as
assessed by colloidal carbon deposition) or IC accumulation
(Fig. 1, A and B). In contrast, surgical exteriorization of the
cremaster, a step required for IVM, resulted in colloidal
carbon and IC deposition (Fig. 1, C and D). When ICs
were injected immediately after exteriorization, deposits
formed rapidly within 1 min of injection. The surgical-
induced permeability and IC deposition were recapitulated
by administering permeability mediators, histamine or
VEGF, after ICs (Fig. 1, E and F). IC deposition occurred
in postcapillary venules, but not arterioles or capillaries, as
assessed by IVM (Fig. 1, G and H, and Video 1, available at
http://www.jem.org/cgi/content/full/jem.20040501/
DC1). This was confirmed by IHC staining for ICs in fro-
zen muscle sections (not depicted). DNP/anti-DNP ICs
also deposited, indicating that deposition was independent
of IC composition (not depicted). Permeability was in-
creased (not depicted), but IC deposits were not seen in
exteriorized muscles of anesthetized mice given BSA (Fig.
1 I). Also, vascular leakage of FITC-dextran was observed
in the exteriorized cremaster of BSA- or IC-injected mice
(Fig. 1 J), confirming that the surgical manipulation in-
creases permeability.
To examine if IC deposition increased with time, we ex-
teriorized cremasters 4, 8, and 24 h after IC injection. The
amount of IC deposits decreased with time, with none de-
tectable at 24 h, likely reflecting IC clearance (not de-
picted). The granular appearance of IC deposits the de-
crease in platelet counts after IC injection, and reports that
platelets accumulate in venules during Arthus reactions (35)
prompted us to examine whether IC deposits contained
platelets. However, calcein-labeled platelets were not ob-
served at the venule wall with IVM, which was confirmed
by IHC (not depicted).
Although permeability changes after surgical exterioriza-
tion could be due to histamine, PAF, and mast cells (18), this
permeability and IC deposition were not blocked by inhibit-
ing histamine (H1 receptor antagonists), nor was it decreased
in mast cell– (Sl/Sl
 
d
 
, W/W
 
v
 
) or platelet-activating receptor–
deficient mice (not depicted). However, treatment of mice
with R/F, which elevate cAMP and enhance EC barrier
function (36), decreased permeability and IC deposition (IC
deposition scores: control: 4.0 
 
  
 
0.0; R/F: 2.2 
 
  
 
0.3; P 
 
 
 
0.05; 
 
n 
 
  
 
5). In summary, our data strongly indicate that
vascular permeability promotes IC deposition.
 
IC Deposits Are Accessible to Circulating Leukocytes.
 
To
address whether IC deposits are accessible to circulating leu-
kocytes, we determined if previously administered unla-
beled ICs could be detected in vivo by secondary Abs given
alone or coupled to 1 
 
 
 
m microspheres. The microsphere
approach has been used previously to probe adhesion mole-
cule expression on EC surfaces (37). Microspheres accumu-
lated within 1 min of injection in venules of mice given
ICs. Furthermore, Cy3-labeled secondary Ab, given after
the microspheres, delineated IC deposits in vessels of mice
given ICs (Fig. 1 K), but not BSA (Fig. 1 L). Importantly,
significantly more microspheres accumulated in vessels of
mice given ICs (5.6 
 
  
 
1.3/mm
 
2
 
) than BSA (1.7 
 
 
 
 0.2/
mm
 
2
 
; 
 
n 
 
  
 
4; P 
 
  
 
0.03). More ICs were labeled by soluble
versus microsphere-coupled secondary Ab. This was attrib-
uted to dislodging of microspheres by high shear rates, ri-
gidity of microspheres (which limits access to ICs between
ECs), and that more secondary Ab was given alone (80 
 
 
 
g)
than as microsphere conjugates (2.6 
 
 
 
g Ab/2 
 
  
 
10
 
8 
 
micro-
spheres). Together, our data indicate that ICs deposited in
cremaster venules after exteriorization are directly accessible
to macromolecules (IgG) and insoluble particles (micro-
spheres) and thus, by extension, to circulating leukocytes.
 
IC Deposition Is Dependent on C1q, but Does Not Require
C3 or C5. We examined if C1q and C3 were associated
with IC deposits in exteriorized cremaster tissue by IHC.
Table I. Changes in Serum C3 Levels and Peripheral Leukocyte, 
Neutrophil, and Platelet Counts in Mice 1 h after Injection of 
BSA/Anti-BSA ICs (n   12) or BSA Alone (n   8)
ICs BSA
Pre Post Pre Post
C3
( g/ml)
294   41 289   50 209   28 296   41
Leukocyte
( 106/ml)
6.9   0.5 7.9   0.9 6.1   1.1 6.1   0.8
Neutrophils
( 106/ml)
1.1   0.2a 3.8   0.3 0.9   0.1a 3.3   0.5
Platelets
( 109/ml)
1.33   0.05a,b 0.90   0.03 1.35   0.04 1.22   0.06
Note that the increased neutrophil count was not specific to ICs because
a similar increase was observed after injection of BSA alone. These
increases might be the result of adrenaline- (stress) or anesthesia-induced
demargination of leukocytes after i.v. injection of BSA or ICs in
anesthetized mice.
aSignificant difference (P   0.05) comparing pre- and postinjection val-
ues within each group of mice.
bSignificant difference (P   0.05) comparing the difference in values
(pre- minus postinjection) between mice given ICs and BSA.Stokol et al. 839
In mice given ICs, C1q colocalized, in a punctuate fashion,
with rabbit IgG within vessels, whereas neither were de-
tected in mice given BSA (Fig. 2 A), suggesting that pre-
formed ICs activate and incorporate C1q. In contrast, C3
was identified diffusely in vessels of WT mice (but was ab-
sent in C3 /  mice) given ICs or BSA (not depicted),
which might be due to continuous low level “Ag-indepen-
dent” complement activation in vivo (38).
Next, we examined whether C1q, C3, or C5 was re-
quired for IC deposition in our model, using relevant KO
mice with WT controls. There were no differences in IC
deposition in cremaster venules of C3 /  or C5 /  com-
pared with WT mice (n   6). However, IC deposition was
significantly decreased in C1q /  compared with WT mice
(Fig. 2, B–D), despite similar increases in permeability (not
depicted). This suggests that C1q, but not C3 or C5, is
largely responsible for IC deposition in this model.
In certain microvessels ECs express Fc Rs, which could
directly bind ICs (39). However, IC deposition was unal-
tered in mice lacking all three Fc Rs (Fc R / ; n   6, not
depicted), suggesting that Fc Rs are not required for depo-
sition of circulating ICs.
IC Deposition Triggers Leukocyte Recruitment That Is Partly
Dependent on P-Selectin. Next, leukocyte recruitment in
cremaster venules was examined by IVM after i.v. injection
of ICs, BSA, or PBS. Leukocyte rolling flux fractions (i.e.,
numbers of cells initiating vessel wall contact), velocity of
rolling leukocytes (slow rolling facilitates adhesion; refer-
ence 40), and adhesion and emigration were measured.
Leukocyte rolling flux fractions in WT mice given ICs,
BSA, or PBS were similar (Fig. 3 A). However, rolling ve-
locity was significantly (P   0.05) slower in mice given ICs
(median: 21  m/s) compared with BSA (median, 55  m/s)
or PBS (median, 53  m/s; n   200–260 leukocytes/group).
Furthermore, leukocyte adhesion was significantly increased
after IC, compared with BSA or PBS, injection (Fig. 3 B).
Thus, ICs do not affect numbers of rolling leukocytes, but
significantly slow rolling velocity, which may favor adhe-
sion, by prolonging transit times (26). Most of the interact-
ing leukocytes were PMN (Fig. 3 C), which comprised
69   2% of intravascular leukocytes on whole mounts.
Figure 1. ICs deposit in cremaster muscle venules after induction of
vascular permeability and are accessible to circulating leukocytes. (A–F) De-
posits of colloidal carbon and ICs (BSA/anti-BSA) were visualized using
phase contrast and fluorescent microscopy, respectively, in cremaster
whole mounts of mice given prelabeled (Cy-3 anti–rabbit IgG) ICs fol-
lowed by colloidal carbon i.v. (n   3 per experiment). (A and B) Mice
were killed after colloidal carbon and IC injection and their cremasters
were harvested. No deposits of colloidal carbon (A) or ICs (B) were seen
(bar, 100  m). (C and D) The cremaster was exteriorized after colloidal
carbon and IC injection, and then harvested. Granular deposits of colloidal
carbon (C) and ICs (D) delineated venules (bar, 50  m). (E and F) Hista-
mine or VEGF (not depicted) was given i.p. between colloidal carbon
and IC injections. Mice were then killed and their cremasters were har-
vested. Colloidal carbon (E) and ICs (F) deposited, mimicking that after
cremaster exteriorization (bar, 50  m). (G–I) Mice were given FITC-
prelabeled ICs (G and H) or BSA and FITC anti–rabbit IgG (I). Their
cremasters were then exteriorized under anesthesia and visualized with
IVM. (G) IC deposits occurred in postcapillary venules (arrows), but not
arterioles (arrowhead; bar, 35  m). (H) Granular IC deposits delineated
venules, but did not extend into capillaries (arrows; bar, 35  m). (I) Dif-
fuse vascular staining was seen in the muscles of mice given BSA and
FITC secondary Ab (bar, 70  m). (J) FITC-dextran, given i.v., diffused
into the extravascular space around venules (arrows), but not arterioles
(arrowhead) of exteriorized cremasters of mice given ICs (H), PBS, or
BSA (not depicted), indicating surgical-induced permeability (bar, 240
 m). (K and L) Unlabeled ICs (K) or BSA (L) were injected i.v. after cre-
master exteriorization in anesthetized mice. 1  m secondary Ab-coupled
microspheres were then given, followed by Cy3-labeled secondary Ab.
More microspheres (yellow) accumulated in venules after IC than BSA
injection. Cy3-Ab (red) identified IC deposits only in vessels of IC-injected
mice (bar, 50  m). See Video 1.Immune Complex Deposition and Leukocyte Recruitment 840
Leukocyte rolling in the exteriorized mesentery (21) and
cremaster (41) is mediated by P-selectin, which might be
constitutively expressed and/or up-regulated after surgery
(12, 42). Therefore, we examined rolling and adhesion in
P-selectin /  and WT mice in response to ICs or controls
(BSA or PBS). IC deposition and permeability changes
were similar in WT and P-selectin /  mice (not depicted).
Rolling was largely abolished in P-selectin /  mice (Fig. 3
A), regardless of treatment. This was associated with de-
creased adhesion compared with WT mice, which was
comparable among treatments (IC: 55%; BSA: 46%; PBS:
68%). These findings suggest that P-selectin is not up-regu-
lated in response to ICs and that P-selectin–mediated roll-
ing facilitates adhesion regardless of the applied stimulus.
Figure 2. Deposition of ICs is dependent on C1q. (A) C1q
colocalizes with rabbit IgG (see arrow for orientation) in
venules of WT mice given ICs (left), but staining for both
was absent in WT mice given BSA (right; bar, 41  m).
C1q staining was absent in C1q /  mice (not depicted).
(B) Decreased staining of labeled ICs is observed in venules
of C1q /  (right) compared with WT mice (left) under
IVM (bar, 35  m). (C) Decreased staining for rabbit IgG is
seen in C1q /  (right, grade 1 ) compared with WT mice
(left, grade 4 ) with IHC (bar, 50  m). (D) To semiquan-
tify the deposited rabbit IgG with IHC, the anti–rabbit Ab
was serially diluted. Staining was stronger in WT com-
pared with C1q /  mice at each dilution and disappeared
from C1q /  mice at twofold lower dilutions than WT
mice. Numbers of mice with detectable vascular staining is
shown in parentheses.Stokol et al. 841
Importantly, adhesion was significantly increased in P-selec-
tin /  mice after ICs compared with controls (Fig. 3 B).
Indeed, WT and P-selectin /  mice showed a similar in-
crease in adhesion (2.7- and 2.8-fold) after IC injection
compared with controls. This suggests that ICs may induce
adhesion in the absence of P-selectin–mediated rolling.
Leukocyte Adhesion Is Mediated by Fc  Receptors on Circulat-
ing Leukocytes. Fc R I, II, and III are expressed on murine
macrophages, whereas mast cells and PMN constitutively ex-
press Fc RII (an inhibitory receptor) and Fc RIII (39). We
tested the hypothesis that IC-induced leukocyte recruitment
in WT and P-selectin /  mice in our in vivo model was due
to the interaction of circulating leukocyte Fc Rs with depos-
ited ICs. Rolling flux fractions following ICs or BSA were
similar in WT mice and mice deficient in all three FcgRs
(Fc R / ; not depicted). However, the IC-induced
slow leukocyte rolling observed in WT mice was absent in
Fc R /  mice (Video 2, available at http://www.jem.org/
cgi/content/full/jem.20040501/DC1, and Fig. 4 A). Also,
leukocyte adhesion was significantly reduced in IC-treated
Fc R /  mice (Video 2) and was similar to that in BSA-
treated mice (Fig. 5 A). These results suggest a critical role for
Fc Rs in IC-induced slow leukocyte rolling and adhesion.
Next, IVM was performed in mice lacking only Fc-
 RIII. Again, rolling flux fractions were similar between
treated WT and Fc RIII /  mice (not depicted). IC-
induced slow rolling was only partly Fc RIII dependent
(Fig. 4 B), suggesting additional Fc Rs, absent in Fc R / 
mice, contribute to IC-induced slow rolling. However,
Figure 3. Leukocyte rolling flux fractions and adhesion in WT and
P-selectin /  mice. (A) Leukocyte rolling flux fractions (%) were not sig-
nificantly different (P   0.05) after IC, BSA, or PBS injection in WT
mice. No rolling was observed in P-selectin /  mice after any treatment.
Hemodynamic parameters were similar between all groups of mice (not
depicted). n   4–6. (B) Numbers of adherent leukocytes were signifi-
cantly (P   0.05) increased in WT and P-selectin /  after IC compared
with BSA and PBS injection. Adhesion was proportionally decreased in
P-selectin /  compared with WT mice with all treatments (bars with the
same symbols are significantly different; P   0.05). (C) Chloroacetate-
esterase stain for PMN in plastic-embedded section of a cremaster of a
WT mouse injected with ICs. Most of the interacting cells are PMN
(muscle, red). An original magnification of 500.
Figure 4. Role of Fc Rs in IC-induced slow leukocyte rolling velocity.
Cumulative frequency distribution curves of leukocyte rolling velocities in
venules of (A) Fc R /  ( / ), (B) Fc RIII /  ( / ), and WT cohorts
( / ) 1 h after ICs or BSA (n   292–420 leukocytes/group). ICs signif-
icantly slowed rolling velocity in WT mice. In both genotypes, median
rolling velocities after BSA were similar (P   0.05). Therefore, results
were combined. (A) After ICs, rolling velocities were slower (P   0.05)
in WT compared with Fc R /  mice, which were similar to BSA controls.
(B) After ICs, rolling velocities were slower (P   0.05) in WT than in
Fc RIII /  mice, which in turn were slower (P   0.05) than BSA controls.Immune Complex Deposition and Leukocyte Recruitment 842
IC-induced adhesion was decreased in Fc RIII /  mice to
similar levels as Fc R /  mice (Fig. 5 A; P   0.05). Thus
IC-induced adhesion is critically dependent on Fc RIII,
whereas slow rolling requires additional Fc Rs.
The Fc R-dependent slow rolling and adhesion after
ICs support a primary role for leukocyte Fc Rs in IC-
induced leukocyte recruitment. However, ICs can bind di-
rectly to Fc Rs on mast cells, releasing factors that could
promote PMN recruitment (18). Thus, we examined re-
cruitment in Sl/Sld and W/Wv mast cell KO mice. In both
strains, rolling flux fractions, shown earlier to be P-selectin
dependent, were significantly reduced (not depicted), whereas
IC-induced adhesion was mildly, but not significantly, de-
creased compared with WT controls (Fig. 5 A). This sug-
gests that mast cells may mediate some P-selectin–depen-
dent rolling, but are not required for Fc R-dependent
adhesion in this model.
P-Selectin and Fc RIII Have Distinct, but Overlapping,
Roles in IC-mediated Leukocyte Adhesion. To address the
possibility that P-selectin–mediated rolling facilitates Fc-
 RIII-dependent adhesion, we determined whether adhe-
sion would be abolished if Fc RIII /  mice are rendered
P-selectin deficient. Thus, Fc RIII /  and WT mice were
given 20  g of a functional blocking mAb against P-selectin.
P-selectin /  mice were given the same mAb as controls.
The mAb abolished rolling in WT and Fc RIII /  mice,
but did not affect IC deposition or permeability (not de-
picted). In WT mice, the mAb decreased adhesion to values
similar to that in P-selectin /  mice given ICs alone or with
the mAb (Fig. 5 B), thus confirming Ab specificity. Adhesion
was significantly decreased in Fc RIII /  mice compared
with WT or P-selectin /  mice given ICs and the mAb (Fig.
5 B). Indeed, there was a proportional decrease in adhesion
in WT (64%) and Fc RIII /  mice (71%) given ICs and
mAb compared with those given ICs alone, suggesting that
the reduced adhesion in these mice is due to the abolition
of P-selectin–mediated rolling. The residual adhesion in
Fc RIII /  given ICs and the mAb was similar to that in
P-selectin /  mice given PBS or BSA alone (refer to Fig. 3 A).
Role of Complement in Leukocyte Adhesion. Comple-
ment, particularly C5a, is critical for IC-induced inflamma-
tion in most models of IC disease (10, 16). However adhe-
sion was not significantly decreased in C5 or C3 KO mice
(Fig. 5 C). There was a trend toward decreased adhesion in
C1q /  mice (by 45%; P   0.056) compared with WT
mice (Fig. 5 C), whereas rolling flux fractions and IC-induced
slow rolling were unaltered (not depicted). The reduced
adhesion was likely a direct consequence of fewer IC de-
posits (Fig. 2). These results indicate that C1q is likely not
required for PMN adhesion, but indirectly affects recruit-
ment due to its role in IC deposition in this model.
Leukocytes Emigrate into Extravascular Tissue in an FcgRIII-
dependent Manner after IC Injection. Because leukocyte ad-
hesion is a prerequisite to emigration (26), we examined
whether leukocytes emigrated into the extravascular tissue
after ICs or BSA. This was done using IVM and the data
was confirmed on cremaster whole mounts only in sets of
mice where a significant decrease in emigration was ob-
Figure 5. Role of Fc Rs, mast cells, and complement in IC-induced
leukocyte adhesion. Because adhesion was similar in genotypes given
BSA alone, values were combined and the mean is represented as a line.
(A) Adhesion was decreased in Fc R /  and Fc RIII /  compared with
WT mice (*, P   0.05) and was similar to BSA controls. Adhesion was
similar in mast cell KO and WT mice, all of which had significantly more
adherent leukocytes compared with BSA controls (297   33 cells/mm2).
(B) Adhesion was decreased (*, P   0.05) in WT and Fc RIII /  mice
given a functional blocking anti–P-selectin mAb (hatched bars) compared
with mice given ICs alone (black bars). Adhesion was unaffected in
P-selectin /  mice given the mAb. The mAb reduced adhesion (#, P  
0.05) in Fc RIII /  compared with WT or P-selectin /  mice. (C) Ad-
hesion was similar in C3 /  or C5 / , but was decreased (P   0.056) in
C1q /  compared with WT mice. All mice had significantly more adher-
ent leukocytes after ICs than BSA (260   56 cells/mm2). See Video 2.Stokol et al. 843
served by IVM. Significantly, more leukocytes were ob-
served in extravascular tissue after ICs compared with BSA
(Fig. 6). Importantly, although a deficiency in mast cells or
complement (C1q, C3, or C5) had no significant effect on
IC-induced emigration (not depicted), numbers of emi-
grated leukocytes were significantly decreased in Fc R / 
and Fc RIII /  mice compared with WT, and were simi-
lar to BSA controls (Fig. 6). These results suggest that IC
deposition promotes leukocyte emigration in an Fc RIII-
dependent manner. The numbers of emigrated leukocytes
in IC-injected WT mice were comparable to that observed
4 h after intrascrotal injection of IL-1  (43, 44).
Discussion
The mechanisms by which circulating ICs deposit and
recruit PMN are largely unclear. Here, we present a model
of acute, limited exposure to ICs, coupled to real-time
analysis, which allowed us to delineate the earliest events in
deposition of circulating ICs and PMN recruitment. We
show that circulating ICs do not up-regulate adhesion mol-
ecules in the cremaster vasculature or activate PMN. We
provide evidence that collectively suggests that C1q-bear-
ing ICs deposit in cremaster venules in response to changes
in vascular permeability, with C1q being required for dep-
osition. The deposited ICs are accessible to circulating
PMN and act as a nidus for their recruitment. Recruitment
may occur by direct interaction of PMN low affinity
Fc Rs (Fc RII and III) with the deposited ICs and/or
PMN rolling on P-selectin may interact with IC deposits
via their low affinity Fc Rs (Fc RII and III). This interac-
tion slows their rolling velocity and promotes firm adhe-
sion via Fc RIII. PMN then migrate into extravascular tis-
sue, with ICs possibly acting as chemotaxins (Fig. 7).
Recruited PMN may facilitate clearance of the IC deposits
before returning to the circulation as described previously
in rats (45). Alternatively, persistent deposition of C1q-
containing ICs within vessels, due to chronic exposure to
circulating ICs, may cause IC translocation and retention in
extravascular tissue. This could result in prolonged Fc R/
IC-mediated recruitment and subsequent induction of tis-
sue injury and disease by activating ECs (46, 47).
Our studies show that altered vascular permeability in-
duced by histamine, VEGF, or surgical manipulation is ac-
companied by IC deposition in postcapillary venules. This
pattern of deposition is consistent with established observa-
tions that permeability occurs principally in small veins and
postcapillary venules (27, 48). Similar venular-specific IC
deposition occurs after local histamine injection in human
patients with vasculitis (5, 6), in Arthus reactions (35, 49),
and in a hypersensitivity reaction in guinea pig cheek
pouches (29). The surgical-induced permeability and IC
deposition was attenuated by cAMP-elevating agents,
which increase EC barrier function (36), providing further
evidence that permeability promotes IC deposition. The
correlation between IC deposition and permeability changes
in our and other studies (5, 6, 33, 34) suggests that human
patients with circulating soluble ICs could be predisposed
to localized IC-mediated inflammation if permeability is al-
tered (e.g., secondary to surgery, blunt trauma, or drugs).
Thus, vasoactive factors may have a causative or perpetuat-
ing role in diseases associated with circulating ICs.
Although C1q is required for IgG–IC binding to human
umbilical vein ECs in vitro (7), this study is the first dem-
onstration that C1q-bound ICs localize to the vessel wall
and that C1q is required for permeability-induced IC de-
position in vivo. Administration of ICs i.v. causes rapid
complement activation through the classical pathway (34),
which is triggered when C1q binds to the Fc region of ad-
jacent IgG molecules in ICs (50). Several mechanisms
Figure 6. Leukocyte emigration in response to IC injection is mediated
by Fc RIII. Numbers of emigrated leukocytes under transillumination
were significantly increased in WT mice (black bars) given ICs rather
than BSA (14   4 cells/mm2). Emigration was decreased after ICs in
Fc R /  and Fc RIII /  (gray bars) compared with WT (black bars; *, P  
0.05), and was similar to BSA controls (n   4–7). These observations
were confirmed in Giemsa-stained whole mounts (n   3). Counts are
higher with this method because stained cells are easier to visualize.
Figure 7. Proposed model for leukocyte recruitment to deposited ICs.
Soluble ICs deposit in postcapillary venules, secondary to increased vascular
permeability. Deposition is facilitated by C1q. (A) PMN tether via P-selectin.
(B) Rolling PMN encounter deposited ICs, which slows their rolling veloc-
ity, which is critically dependent on Fc Rs. (C) Subsequent adhesion is
mediated primarily through Fc RIII. In the absence of P-selectin, direct
interactions of PMN Fc RIII with deposited ICs may cause adhesion.
(D) Lumen-bound ICs and/or ICs diffused extravascularly promote PMN
emigration into the extravascular tissue, an Fc RIII-dependent process.Immune Complex Deposition and Leukocyte Recruitment 844
could promote deposition of C1q-containing ICs within
the vessel wall. In vitro studies suggest the existence of a
putative C1q receptor on ECs (7, 8), although a bona fide
receptor has not yet been identified (43, 51). In vivo, we
propose that vascular permeability factors may induce these
receptors, thus allowing binding of C1q-containing ICs. It
is also probable that C1q binds to extracellular matrix mol-
ecules exposed through permeability changes because C1q
interacts with laminin and fibronectin (52, 53). In addition,
C1q could modify the lattice structure of ICs (1), which
could facilitate IC deposition. Finally, the residual IC
deposition in C1q /  mice might be due to ICs binding di-
rectly to vitronectin or fibronectin (53, 54).
IC-induced complement activation produces chemotaxins
(C3a and C5a; reference 20) and is critical for leukocyte re-
cruitment in various murine models of IC-mediated disease
(10, 17). Despite this, C3 and C5 were not required for re-
cruitment in our model. This might be due to the relative
absence of C3 activation after injection of a single dose of
ICs, despite initial binding of C1q. It is likely that injected
ICs rapidly bind and activate C1q, but further C activation is
down-regulated by inhibitors (9, 55), thus preventing sys-
temic inflammatory effects. C3 and C5 activation is likely
pronounced during chronic IC exposure and may have a di-
rect or indirect (via increased adhesion receptor expression)
role in leukocyte accumulation under these conditions.
Our data indicate a critical role for Fc RIII in mediating
leukocyte adhesion in response to ICs in vivo. This data is
in concert with previous results showing that neutrophils
bind via Fc RIII to ICs under physiological flow in vitro
(19). Notably, IC-induced adhesion occurred in the ab-
sence of increased rolling flux fractions, indicating that the
IC-induced adhesion is not the result of increased numbers
of rolling cells. However, maximal interaction with ICs ap-
pears to require P-selectin and Fc Rs, suggesting that roll-
ing may facilitate the Fc R-mediated adhesion to ICs.
Rolling in this model is likely due to constitutive P-selectin
expression (12) or mast cell–mediated up-regulation with
cremaster exteriorization (42). Our results suggest that
Fc Rs, particularly Fc RIII, might be solely responsible
for leukocyte recruitment to ICs in vascular beds lacking
constitutive P-selectin expression, e.g., the glomerulus (56).
Indeed, mice lacking Fc Rs have reduced glomerular PMN
accumulation in acute nephritis models (19, 57).
Although ICs did not alter rolling flux fractions, the
velocity of P-selectin–mediated rolling was significantly
slowed in response to ICs, and this was Fc R dependent.
The currently held paradigm in non-IC models of inflam-
mation is that slow rolling and long transit times, rather than
flux fractions, are critical for efficient leukocyte adhesion
(40). The fact that Fc RIII alone was not responsible for
the Fc R-dependent, IC-induced slow rolling velocity sug-
gests that Fc RII or a new   chain–containing Fc R (58) is
required for this step. Adhesion in response to ICs was criti-
cally dependent on Fc RIII, likely because Fc RIII trans-
mits the activating signals for adhesion in murine PMN (59,
60). These data provide a possible mechanism for the re-
duced inflammation observed in Fc RIII /  mice in several
models of IC-mediated disease (10, 19, 60). Fc Rs are also
expressed by mast cells (39), yet they played a minimal role
in early PMN recruitment after circulating IC deposition.
However, once ICs diffuse into extravascular tissue, it is
likely that tissue mast cells or macrophages have an impor-
tant role in the unfolding inflammatory response.
Finally, IC promoted leukocyte emigration that was
entirely Fc RIII dependent, suggesting that ICs might be
chemotactic, as reported in vitro (61). ICs may promote
leukocyte emigration in an analogous fashion to surface-
embedded chemokines, which can induce transendothelial
migration under shear conditions without the presence of a
chemotactic gradient (62). The increased extravasation may
also be a direct consequence of IC-induced leukocyte adhe-
sion. Emigration (as measured under transillumination) was
reduced in P-selectin /  mice (WT: 64   33 cells/mm2;
P-selectin / : 20   4 cells/mm2; P   0.22), which paral-
leled the decreased adhesion in these mice. Thus, although
adherence may promote emigration in our model, a chemo-
tactic effect of ICs may also be operative and our results do
not distinguish between these possibilities.
In summary, we have developed a model of acute IC-
induced inflammation that allows visualization of the earli-
est events contributing to IC deposition and subsequent
PMN accumulation. This model has relevance for human
patients with diseases associated with high concentrations
of circulating ICs, e.g., systemic lupus erythematosus, and
is distinguished from other acute IC models, e.g., the re-
verse Arthus reaction, in which ICs are primarily generated
in extravascular tissues (14, 49). Here, we show that ICs
deposit within vessels in response to increased permeability
and trigger rapid PMN accumulation by slowing PMN
rolling velocity and promoting adhesion. IC deposition is
dependent on C1q activation and this might be one of the
earliest events permitting IC deposition in vessels in pa-
tients with IC-mediated diseases. The lack of an apparent
role for C3 and C5 in IC deposition suggests that further
complement activation is not required for this step. Fc Rs,
particularly Fc RIII, are required for several aspects of the
subsequent IC-mediated PMN recruitment, namely slow-
ing rolling velocity and mediating adhesion and emigra-
tion. Together, these data suggest sequential, noninteract-
ing roles for complement and Fc Rs in this model of
circulating IC-mediated inflammation.
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